Company news
Nuvo Pharmaceuticals Inc news in 2017
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2017, newest first.
Nuvo Pharmaceuticals(TM) Enters into Pennsaid® 2% License Agreement with Gebro Pharma AG for Switzerland and Liechtenstein
December 14, 2017
Nuvo Pharmaceuticals(TM) Announces Normal Course Issuer Bid
November 30, 2017
Nuvo Pharmaceuticals(TM) Commences Trading on the OTCQX® Market in the U.S.
November 28, 2017
Nuvo Pharmaceuticals(TM) Announces Appointment of Jesse Ledger as President & Chief Executive Officer
November 22, 2017
Nuvo Pharmaceuticals(TM) Announces 2017 Third Quarter Results
November 1, 2017
Nuvo Pharmaceuticals(TM) Secures Credit Facility from the Royal Bank of Canada
August 24, 2017
Nuvo Pharmaceuticals(TM) Announces 2017 Second Quarter Results
August 9, 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid® 2%
May 15, 2017
Nuvo Pharmaceuticals(TM) Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent
May 15, 2017
Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
May 11, 2017
Nuvo Pharmaceuticals(TM) Announces 2017 First Quarter Results
May 10, 2017
Nuvo Pharmaceuticals(TM) Enters into Pennsaid® 2% License Agreement with Sayre Therapeutics PVT Ltd. for India, Sri Lanka, Bangladesh and Nepal
March 28, 2017
Nuvo Pharmaceuticals(TM) Announces 2016 Year-End and Fourth Quarter Results
March 1, 2017